ʻO SARS-CoV-2 Antigen Rapid Test Cassette
ʻO ka wehewehe pōkole:
ʻO ka SARS-CoV-2 Antigen Rapid Test Cassette he immunoassay chromatographic wikiwiki no ka ʻike qualitative o SARS-CoV-2 antigen i nā swabs Oropharyngeal kanaka. CoV-2. Ua manaʻo ʻia e kōkua i ka hōʻoia ʻokoʻa wikiwiki o ka maʻi COVID-19.
KA MANAO ANA
ʻO kaʻO SARS-CoV-2 Antigen Rapid Test Cassettehe immunoassay chromatographic wikiwiki no ka ʻike qualitative o SARS-CoV-2 antigen i loko o nā swabs Oropharyngeal kanaka. Hoʻokumu ʻia ka ʻike ma nā antibodies monoclonal kikoʻī no ka Nucleocapsid (N) Protein o SARS-CoV-2. ka hōʻoia ʻokoʻa wikiwiki oCOVID-19maʻi maʻi.
Nā ʻōlelo kikoʻī
25 ho'āʻo/pack, 50 hoʻāʻo/pack, 100 ho'āʻo/pack
OLELO HOOLAHA
No ka β genus ka coronaviruses hou.COVID-19He maʻi maʻi ʻeha ʻeha. He maʻi maʻamau ka poʻe. I kēia manawa, ʻo ka poʻe maʻi i loaʻa i ka coronavirus novel ke kumu nui o ka maʻi; hiki i ka poʻe maʻi asymptomatic ke kumu maʻi. a hiki i 14 lā, ʻo ka hapa nui 3 a 7 lā. ʻO nā hōʻike nui e pili ana i ke kuni, ka luhi a me ka ʻū maloʻo. Loaʻa ka nasal congestion, runny ihu, ʻeha ʻāʻī, myalgia a me ka maʻi maʻi i kekahi mau hihia.
NA REAGENA
Aia ka cassette hōʻike i nā ʻāpana protein anti-SARS-CoV-2 Nucleocapsid a me anti-SARS-CoV-2 Nucleocapsid protein i uhi ʻia ma ka membrane.
MAHELE
E ʻoluʻolu e heluhelu i ka ʻike a pau i loko o kēia pūʻolo hoʻokomo ma mua o ka hana ʻana i ka hoʻāʻo.
1. No ka 'oihana in vitro diagnostic hoʻohana wale. Mai hoʻohana ma hope o ka lā pau.
2. Pono ka ho'āʻo i loko o ka ʻeke i hoʻopaʻa ʻia a hiki i ka mākaukau e hoʻohana.
3. Pono e noʻonoʻo ʻia nā mea hoʻohālike a pau he mea pōʻino a mālama ʻia ma ke ʻano like me ka mea maʻi maʻi.
4. Pono e hoʻolei ʻia ka hoʻāʻo i hoʻohana ʻia e like me nā kānāwai kūloko.
5.Avoid hoʻohana i nā laʻana koko.
6.Wear nā mīkina lima i ka hāʻawi ʻana i nā laʻana, e pale i ka hoʻopā ʻana i ka membrane reagent a me ka laʻana maikaʻi.
HOOLAHA A ME KA PALAPALA
ʻO 18 mahina ka manawa kūpono inā mālama ʻia kēia huahana ma kahi o
2-30 ℃. Paʻa ka hoʻokolohua ma o ka lā pau i paʻi ʻia ma ka ʻeke i hoʻopaʻa ʻia..MA'I HOOMAIKAI.Mai hoʻohana ma mua o ka lā pau.
OHI A ME KA HOOMAKAUKAU
1. ʻOhi huna puʻu: E hoʻokomo i kahi swab sterile i loko o ka ʻāʻī loa mai ka waha, e kau ana ma ka paia o ka puʻu a me ka ʻāpana ʻulaʻula o ka palate tonsils, holoi i ka bilateral pharyngeal tonsils a me ka paia pharyngeal hope me ka haʻahaʻa.
e hoʻoikaika, e pale i ka hoʻopā ʻana i ke alelo a e wehe i ka swab.
2. E hana koke i ka hāpana me ka hāpana hoʻoheheʻe i hāʻawi ʻia i loko o ka pahu ma hope o ka hōʻiliʻili ʻana o ka hāpana. Inā ʻaʻole hiki ke hana koke ʻia, pono e mālama ʻia ka hāpana i loko o kahi pahu plastik maloʻo, sterilized a hoʻopaʻa paʻa ʻia. Hiki ke mālama ʻia ma 2-8 ℃ no 8 mau hola, a hiki ke mālama ʻia no ka manawa lōʻihi ma -70 ℃.
3. ʻAʻole hiki ke hoʻohana ʻia nā laʻana i hoʻohaumia nui ʻia e nā koena meaʻai waha no ka hoʻāʻo ʻana i kēia huahana. ʻAʻole ʻōlelo ʻia nā laʻana i hōʻiliʻili ʻia mai nā swabs a i ʻole agglomerated no ka hoʻāʻo ʻana i kēia huahana. Inā haumia nā swabs me ka nui o ke koko, ʻaʻole ʻōlelo ʻia no ka hoʻāʻo ʻana. ʻAʻole ʻōlelo ʻia e hoʻohana i nā laʻana i hoʻopaʻa ʻia me ka hāʻina hoʻoheheʻe ʻana i hāʻawi ʻole ʻia i loko o kēia pahu no ka hoʻāʻo ʻana i kēia huahana.
NA KOMPONO KITS
Hāʻawi nā mea hana
Nā pahu hoʻāʻo | Mea hoʻoheheʻe ʻia | Paipu unuhi | |
ʻAi ʻAi Maʻemaʻe | Hoʻokomo pūʻolo | Hale Hana |
Pono nā mea pono akā ʻaʻole hāʻawi
Ka manawa | No ka hoʻohana manawa. |
Pūʻolo |
Nā kikoʻī25
nā ho'āʻo/pack50
nā ho'āʻo/pack100
nā ho'āʻo/packSample Extraction Reagent25 ho'āʻo/pack50 ho'āʻo/pack100 ho'āʻo/packSample unuhi
tube≥25 ho'āʻo/pack≥50 ho'āʻo/pack≥100 ho'āʻo/packInstructionE nānā i ka
packageE nānā i ka
packageE nānā i ka
pūʻolo
OLELO HOOLAHA
E ʻae i ka hoʻāʻo, specimen, extraction buffer e hoʻohālikelike i ka lumi wela (15-30 ℃) ma mua o ka hoʻāʻo ʻana.
1. Wehe i ka pahu ho'āʻo mai ka ʻeke pepa i hoʻopaʻa ʻia a hoʻohana i loko o 15 mau minuke. Loaʻa nā hopena maikaʻi loa inā hana ʻia ka hoʻāʻo ma hope koke o ka wehe ʻana i ka ʻeke pepa.
2.Place i ka Extraction Tube i loko o ke kahua hana.E hoopaa i ka omole reagent extraction i luna i lalo. Paipu.
3. E kau i ka mea hoʻoheheʻe i loko o ka Tube Extraction. E hoʻohuli i ka swab ma kahi o 10 kekona me ke kaomi ʻana i ke poʻo i loko o ka paipu e hoʻokuʻu i ka antigen i loko o ka swab.
4. Wehe i ka swab i ka wā e ʻomi ai i ke poʻo swab i loko o ka Extraction Tube i kou wehe ʻana iā ia e kipaku aku i ka wai e like me ka hiki.
5. E hoʻokomo i ka piko hoʻoheheʻe ma luna o ka paipu unuhi. E kau i ka pahu hoʻāʻo ma kahi maʻemaʻe a pae.
6.Add 2 drops of the solution(approx,65μL) to the sample well a laila hoʻomaka i ka timer.E heluhelu i ka hopena i hōʻike ʻia i loko o 20-30 minuke, a ʻaʻole pono nā hualoaʻa ma hope o 30 mau minuke.
KA WAIWAI O NA HUNAHUNA
NEGATIVE HUA: |
Hōʻike ʻia kekahi laina kala ma ka ʻāpana laina mana (C). ʻAʻohe laina i ʻike ʻia ma ka ʻāpana hoʻāʻo (T). Hōʻike ka hopena maikaʻi ʻole ʻaʻole i loaʻa ka antigen SARS-CoV-2 i loko o ka specimen, a i ʻole aia ma lalo o ka pae ʻike ʻia o ka hōʻike.
PONOHUA:
Aia nā laina ʻelua. aia kekahi laina kala ma ka ʻāpana hoʻomalu (C) a aia kekahi laina kala ʻē aʻe ma ka ʻāpana hoʻāʻo (T).
KA HOʻOPIʻI OLE:
ʻAʻole ʻike ʻia ka laina hoʻomalu. E nānā i ke kaʻina hana a hana hou i ka hoʻāʻo me kahi hoʻāʻo hou. Inā hoʻomau ka pilikia, e hoʻopau koke i ka hoʻohana ʻana i ka pahu hoʻāʻo a hoʻopili i kāu mea hoʻolaha kūloko.
MANAʻO:
E ʻokoʻa ka ikaika o ke kala ma ka ʻāpana laina hoʻāʻo (T) ma muli o ke ʻano o ka SARS-CoV-2 Antigen i loaʻa i ka specimen. No laila, pono e noʻonoʻo ʻia kekahi malu o ka waihoʻoluʻu ma ka ʻāpana laina hoʻāʻo (T).
HOOLAHA ANOAI
- Hoʻokomo ʻia kahi mana kaʻina hana i ka hoʻāʻo. ʻO kahi laina kala e ʻike ʻia ana ma ka ʻāpana hoʻomalu (C) i manaʻo ʻia he mana kaʻina hana kūloko.
- ʻAʻole hoʻolako ʻia nā kūlana mana me kēia kit; akā naʻe, manaʻo ʻia e hoʻāʻo ʻia nā mana maikaʻi a maikaʻi ʻole ma ke ʻano he hana hoʻokolohua maikaʻi e hōʻoia i ke kaʻina hana hoʻāʻo a e hōʻoia i ka hana hoʻokolohua kūpono.
KAUKANO KA HOAO
- ʻO ka SARS-CoV-2 Antigen Rapid Test Cassette no ka hoʻohana diagnostic in vitro wale nō. Hiki ke hoʻoholo ʻia ka ʻike CoV-2 e kēia hoʻokolohua qualitative.
- ʻO ka pololei o ka hoʻāʻo ʻana ma muli o ka maikaʻi o ka swab sample.False negatives hiki ke hoʻopuka i ka waiho ʻana o ka hōʻiliʻili laʻana.
- ʻO ka SARS-CoV-2 Antigen Rapid Test Cassette e hōʻike wale ana i ka hele ʻana o SARS-CoV-2 i loko o ka specimen mai nā kānana coronavirus SARS-CoV-2 hiki ke ola.
- E like me nā hoʻokolohua diagnostic āpau, pono e unuhi ʻia nā hopena āpau me nā ʻike lapaʻau ʻē aʻe i loaʻa i ke kauka.
- Pono e hōʻoia ʻia kahi hopena maikaʻi ʻole mai kēia kit e PCR. Hiki ke loaʻa ka hopena maikaʻi ʻole inā ʻaʻole lawa ka ʻike o ka SARS-CoV-2 i loko o ka swab a i ʻole ma lalo o ka pae ʻike ʻia o ka hoʻāʻo.
- Hiki ke hoʻopilikia i ka hana ʻana o ke koko nui a i ʻole ka ʻūhū ma luna o ke ʻano o ka swab a loaʻa i kahi hopena maikaʻi ʻole.
- ʻO kahi hopena maikaʻi no SARS-CoV-2 ʻaʻole ia e pale i kahi maʻi maʻi i lalo me ka anther pathogen. No laila, pono e noʻonoʻo ʻia ka hiki ʻana o kahi maʻi bacterial unerlying.
- ʻAʻole ʻae nā hopena maikaʻi ʻole i ka maʻi SARS-CoV-2, ʻoi aku hoʻi i ka poʻe i pili me ka maʻi. Pono e noʻonoʻo ʻia ka hoʻāʻo ʻana me ka diagnostic molecular e kāpae i ka maʻi i loko o kēia poʻe.
- Loaʻa paha nā hopena maikaʻi ma muli o ka maʻi i kēia manawa me nā kānana coronavirus non-SARS-CoV-2, e like me ka coronavirus HKU1, NL63, OC43, a i ʻole 229E.
- ʻAʻole pono e hoʻohana ʻia nā hopena mai ka hoʻāʻo antigen ma ke kumu hoʻokahi e ʻike ai a kāpae ʻia i ka maʻi SARS-CoV-2 a i ʻole e hoʻomaopopo i ke kūlana maʻi.
- Hiki i ka Extraction reagent ke pepehi i ka maʻi maʻi , akā ʻaʻole hiki ke hoʻopau i ka 100% o ka maʻi. ʻO ke ʻano o ka hoʻopau ʻana i ka maʻi maʻi hiki ke kuhikuhi ʻia: he aha ke ʻano i ʻōlelo ʻia e WHO / CDC, a i ʻole hiki ke mālama ʻia e like me nā lula kūloko.
NA HIO HANA
ʻO ka ʻikeakikoo
ʻO ka SARS-CoV-2 Antigen Rapid Test Cassette ua loiloi ʻia me nā specimens i loaʻa mai ka poʻe maʻi.
ʻano hana | RT-PCR | Huina hopena | ||
ʻO SARS-CoV-2 Antigen Rapid Test Cassette | Nā hualoaʻa | maikaʻi | ʻinoʻino | |
maikaʻi | 38 | 3 | 41 | |
ʻinoʻino | 2 | 360 | 362 | |
Huina hopena | 40 | 363 | 403 |
Pilikino Pili:95.0%(95%CI*:83.1%-99.4%)
ʻIkepili pili:99.2%(95%CI*:97.6%-99.8%)
* Nā Kūlana hilinaʻi
Ka palena ʻike
Ke ʻoi aku ka nui o ka maʻi maʻi ma mua o 400TCID50/ml, ʻoi aku ka nui o ka helu ʻike maikaʻi ma mua o 95%. Ke emi ka maʻi maʻi ma mua o 200TCID50/ml, ʻoi aku ka liʻiliʻi o ka helu ʻike maikaʻi ma mua o 95%, no laila ʻo 400TCID ka palena haʻahaʻa loa o kēia huahana.50/ml.
Ka pololei
Ua hoʻāʻo ʻia ʻekolu mau pūʻulu reagents no ka pololei. Ua hoʻohana ʻia nā ʻāpana like ʻole o nā reagents no ka hoʻāʻo ʻana i ka hāpana like ʻole he 10 mau manawa i ka holomua, a ʻo nā hopena a pau ʻino. Ua hoʻohana ʻia nā ʻāpana like ʻole o nā reagents e hoʻāʻo i ka laʻana maikaʻi like 10 mau manawa i ka holomua, a ua maikaʻi nā hopena.
hopena HOOK
Ke hiki i ka maʻiʻo maʻiʻo i loko o ka hāpana e hoʻāʻo ʻia a hiki i 4.0*105TCID50/ml, ʻaʻole hōʻike ka hopena hoʻāʻo i ka hopena HOOK.
Kea-Reactivity
Ua loiloi ʻia ka hoʻololi ʻana o ka pahu. ʻAʻole i hōʻike ʻia nā hopena i ka hoʻoikaika ʻana me kēia ʻano hoʻohālike.
inoa | Hoʻopaʻa |
HCOV-HKU1 | 105TCID50/ml |
ʻO Staphylococcus aureus | 106TCID50/ml |
ʻO ka hui A streptococci | 106TCID50/ml |
Maʻi ʻino | 105TCID50/ml |
ʻO ka maʻi maʻi mumps | 105TCID50/ml |
ʻO Adenovirus ʻano 3 | 105TCID50/ml |
Mycoplasmal pneumonia | 106TCID50/ml |
Paraimfluenzavirus, ʻano 2 | 105TCID50/ml |
ʻO ka metapneumovirus kanaka | 105TCID50/ml |
ʻO ka coronavirus kanaka OC43 | 105TCID50/ml |
ʻO ka coronavirus kanaka 229E | 105TCID50/ml |
ʻO Bordetella parapertusis | 106TCID50/ml |
Influenza B Victoria STRAIN | 105TCID50/ml |
Influenza B YSTRAIN | 105TCID50/ml |
Influenza A H1N1 2009 | 105TCID50/ml |
Influenza A H3N2 | 105TCID50/ml |
H7N9 | 105TCID50/ml |
H5N1 | 105TCID50/ml |
ʻO ka maʻi virus Epstein-Barr | 105TCID50/ml |
Enterovirus CA16 | 105TCID50/ml |
Rhinovirus | 105TCID50/ml |
Respiratory syncytial virus | 105TCID50/ml |
Streptococcus pneumoni-ae | 106TCID50/ml |
ʻO Candida albicans | 106TCID50/ml |
Chlamydia pneumoniae | 106TCID50/ml |
ʻO Bordetella pertussis | 106TCID50/ml |
Pneumocystis jiroveci | 106TCID50/ml |
Mycobacterium tuberculosis | 106TCID50/ml |
Legionella pneumophila | 106TCID50/ml |
Imea keakea
ʻAʻole e hoʻopilikia ʻia nā hopena hōʻike me ka mea ma ke ʻano aʻe:
Ke keakea nei mea waiwai | Conc. | Mea keakea | Conc. |
Koko holookoa | 4% | Huihui Benzoin Gel | 1.5mg/ml |
Ibuprofen | 1mg/ml | Cromolyn glycate | 15% |
ʻo ka tetracycline | 3ug/ml | chloramphenicol | 3ug/ml |
Mucin | 0.5% | ʻO Mupirocin | 10mg/ml |
Erythromycin | 3ug/ml | Oseltamivir | 5mg/ml |
ʻO Tobramycin | 5% | Naphazoline Hydrochlo-ride Nasal Drops | 15% |
menthol | 15% | Fluticasone propionate spray | 15% |
Afrin | 15% | Deoxyepinephrine hydro-chloride | 15% |
IBIBLIOGRAPHY
1. Weiss SR, Leibowitz JZ. ʻO ka maʻi maʻi coronavirus. Adv Virus Res 2011;81:85-164
2.Cui J,Li F,Shi ZL.Origin and evolution of pathogenic coronaviruses.Nat Rev Microbiol 2019;17:181-192.
3.Su S, Wong G, Shi W, et al.Epidemiology, genetic recombination, and pathogenesis of coronaviruses. TrendsMicrobiol 2016;24:490-502.